Tag Archives: Neurochemical

neurotransmitters-and-mood-symptoms

Neurochemical basis of addiction

Neurochemical basis

Neurochemical basis of addiction and addiction treatment systems

Neurochemical basis of addiction: The depleted GABA

For a long time, various forms of addictions have been taken to be just as a result of social problems and sometimes even decisions or choices we make in life. Yes, this may be true but we need to take a moment and look into this problem more critically to find facts about the neurochemical basis of addiction. Doctor Dalal Akoury MD, President, and founder of the AWAREmed health and wellness resource center says that it’s good that modern addiction medicine now recognizes that substance dependency of any kind is a disease process of the brain that features lowered dopamine and glutamate neurotransmitter levels. Importantly, as more legitimate research is done in this field of addiction medicine whose experimental basis is beginning to gain ground, models of neurochemical bases of addiction in the future may also feature lowered levels of GABA as the disease progresses. To understand this neurotransmitter (GABA) it will be necessary that we try to define some of the terms associated with it and appreciate the roles and functions of GABA in totality.

The use of GABA

Because of our unique DNA and the way that each of us metabolizes drugs, each of us may have different amounts of GABA in the brain but we are still considered to be operating “normally.” Unfortunately, there are no accepted medical tests to determine if we have too much or too little GABA activity. It appears that people who are nutritionally deficit and dehydrated often have problems with the operation of GABA in their brains. Since almost all of our patients are nutritionally deficient and dehydrated when they arrive at our facility, we have always implemented the addition of GABA to the IV therapy given to patients. The purpose is to provide a more natural boost to the GABA in the brain and to allow the calming effect of GABA to make the detoxification process more comfortable. Let us now understand how GABA operates by defining these terms.

Neurochemical basis of addiction: The neuron

  • A neuron is another name for a nerve cell.
  • Nerve cells float in the fluid.
  • Each neuron has an axon a thread-like part of the cell that sends signals from the cell body and a dendrite a part of the cell that receives signals from other neurons.
  • The neurons are not touching and the space between the cells is called the synapse.
  • Electrical signals are sent through the synapse to a receptor, a place on a cell that can produce a certain effect like the production of adrenaline if someone is frightened.

Neurochemical basis of addiction: The central nervous system (CNS)

  • The CNS is composed of the brain and the spinal cord.
  • The CNS transmits signals to the rest of the body using chemical messengers called neurotransmitters.
  • Neurotransmitters are stored in vesicles—hollow sac-like structures inside the cells.
  • These neurotransmitters carry a message from a neuron to receptors on another neuron.
  • The action of the neurotransmitters on the receptors has been likened to a key being inserted in a lock.
  • When the key is turned the lock opens and the neurotransmitters activate the receptors which in turn create an effect in the body.
  • Then many of the neurotransmitters return to the releasing vesicles to be used again.

Finally, you can always talk to us by calling doctor Akoury on telephone number 843 213 1480 to help you with any concerns you may have.

Neurochemical basis of addiction: The depleted GABA

http://regenerativepotential.com/wp-admin

 

 

 

Facebooktwitterpinterestlinkedin

Reward Deficiency Syndrome In Addiction

Reward Deficieny syndromeReward Deficiency Syndrome and Its Role in Addiction and Treatment

The first people to come up with the term Reward deficiency syndrome were Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Cull JG and  Comings DE in a research titled; The D2 dopamine receptor gene as a determinant of reward deficiency syndrome in 1996. This term refers to an insufficiency of usual feelings of satisfaction. Reward deficiency syndrome results from a dysfunction in the brain reward system which is a complex interaction among neurotransmitters primarily dopaminergic and opiodergic neurotransmitters. Those who have a family history of alcohol and other drugs addictions may be born with a deficiency in the ability to produce or utilize these neurotransmitters which are known to play crucial in etiology of addiction to substances. This problem can also be caused by corruption of brain reward system that may be caused by exposure to long periods of stress or use of alcohol and other substance for a long time. When the neurotransmitters are low or are blocked from reaching the intended brain receptors, individuals often feel discomfort or pain. Behaviors resulting from a failure of the system that normally confers satisfaction include drug and alcohol abuse, overeating, heavy cigarette smoking, gambling, and hyperactivity. These problems have been linked to genetic defects especially to dysfunction of the dopamine receptors.

A dysfunction in the dopamine receptors obviously leads to myriads of health complications since it is the brain neurotransmitter that controls feelings of well-being and is mostly targeted by drugs of abuse. However powerful dopamine doesn’t work alone, it interacts with other neurotransmitters like serotonin and other neurotransmitters to control moods and cravings. When these neurotransmitters bind on the neural receptors, they trigger a reaction in the reward system, therefore any interference with this coordination will result in abnormal behavior in Reward deficiency syndrome, including addictions, impulsivity, and excessive risk taking. This is the reason why people who have a defect in the DRD2 dopamine receptor gene lack a sufficient number of dopamine receptors in their brains to produce the brain reward cascade. In turn, this leads to Reward deficiency syndrome, including abnormal cravings and resultant strange conduct.

 

Reward deficiency syndrome and Drug Abuse

The reward circuitry consists of an in-series circuit linking the ventral tegmental area, nucleus accumbens and ventral pallidum via the medial forebrain bundle. In the past the reward circuitry was believed to encode only the set point of hedonic tone but have since been found to be functionally far more complex, also encoding attention, expectancy of reward, disconfirmation of reward expectancy, and incentive motivation. Here have been speculations that hedonic dysregulation within the reward circuits may lead to addiction. A second-stage dopaminergic component in this reward circuitry is the crucial addictive-drug-sensitive component. All drugs that are addictive are known to enhance the dopaminergic reward synaptic function in the nucleus accumbens. as for most of addictive drugs like cocaine the tolerance to the euphoric effects will develop after a long term use after which a post use dysphoria then comes to dominate reward circuit hedonic tone, and addicts no longer use drugs to get high, but simply to get back to normal. Reward deficiency syndrome as seen here may make an addict chained to the drug of use since the addict will need to feel normal but that will not possible since the dopamine receptors and parts of the reward circuit will have been affected adversely and so the drug use will be continued as a result of Reward deficiency syndrome and not for euphoric purposes.

It is also important to note that the brain circuits that mediates pleasurable effects of addictive drugs are anatomically, neurophysiologically, and neurochemically different from those mediating physical dependence, and from those mediating craving and relapse. Apart from Reward deficiency syndrome other factors that also come to play in addiction include gene variations that may increase vulnerability to drug addiction. Environmental factors also have an input for example prolonged stress and social defeat may also increase a person’s vulnerability to drug addiction as they alter the brain reward system. However dopaminergic dysfunction within the reward circuitry is the biggest contribution to addiction-prone personality effects.

Treating Reward deficiency syndrome

Reward Deficieny syndromeReward deficiency syndrome has influence in drug addiction and therefore any drug addiction treatment must incorporate strategies to treat Reward deficiency syndrome in order to avoid reoccurrence of the addiction after a hard won fight. In fact when the problem in the reward circuitry isn’t addressed then treatment of addiction will have very narrow chances of success. To help in this pursuit, treatment of cocaine addiction should have in part a dopamine agonist agonistic therapy to heal the dopaminergic system.

When an agonist therapy is to be used, it’s crucial to note that the baseline amount of dopamine receptors has predictability as to differential clinical outcomes in reward deficiency syndrome. In a study of 10 subjects with an allele on the Taq1A DRD2 gene, which is associated with reduced dopamine receptor concentration and decreased neural responses to rewards (A1+ subjects). The 10 subjects were scanned twice, once on placebo and once on cabergoline which is D2 receptor agonist. Consistent with an inverted-U relationship between the DRD2 polymorphism and drug effects, cabergoline increased neural reward responses in the medial orbitofrontal cortex, cingulate cortex, and striatum for A1+ subjects, but decreased reward responses in these regions for A1− subjects.  Drug addiction treatment should therefore put in place measures to ensure that reward deficiency syndrome is treated. Dr. Dalal Akoury of AWAREmed Health and Wellness Center has dedicated her life to helping patients restore their lives by use of integrative medicine. She also holds many conferences in which she offers training on how integrative medicine can be used to fight addiction among other conditions.  Call her on (843) 213-1480 for help.

Reward Deficiency Syndrome and Its Role in Addiction and Addiction Treatment

 

Facebooktwitterpinterestlinkedin

Stem Cell Therapy May Offer an Effective Parkinson’s Disease Treatment

Stem Cell Therapy May Offer an Effective Parkinson’s Disease Treatment

The Parkinson’s disease has affected many people in the past and it still startles to know that this disease is still affecting millions of people across the globe. Doctors have been treating only the symptoms of this disease as there is no known cure of the Parkinson’s disease. Recently there has been lots of research on the field of integrative regenerative medicine to help in treatment of this disease. The stem cell therapy is one of the ways that have been investigated by researchers to establish if there is a possibility of this disease having a known cure which is effective.

Despite the fact that the Parkinson’s disease has no known cure, the cause of this disease is known. This disease is caused by the continued loss of dopamine-producing cells in the brain. Dopamine is a crucial brain chemical that helps to regulate movement and emotional responses among other functions.

When a person is suffering from this disease, he will suffer deficiency of dopamine. The Parkinson’s disease is known to target and kill dopamine-producing nerve cells, or neurons, in part of the brain called the substantia nigra. The effects of Parkinson’s disease on the nerve cells of the brain may be the reason for such problems in sleeping, motivation and thinking that Parkinson’s disease is known for but also it has been linked to the linked to the formation of clumps of a protein called alpha-synuclein in the brain. These abnormal protein clumps are called Lewy bodies and are dangerous in the body.

Continued death of the nerve cells results in Parkinson’s patients developing tremors and rigidity, as well as slowed movements. Other conditions that these patients will suffer from as a result of continued death of the nerve cells in the brain includes depression, sleeping disorders, dementia and even constipation. However dementia may be suffered at a much later stage when the damage on the nerve cells has spread widely. They may also lose their sense of smell.

Parkinson’s Disease

Due to the fact that depletion of dopamine causes Parkinson’s disease, doctors have been utilizing treatments that are useful in boosting the levels of dopamine din the brain. One of the most commonly used treatments is the use of a drug known as the Levodopa. This drug has been in use since 1960s when it was discovered. It works in a manner that supplements dopamine levels as it converts into dopamine while in the body. In this case the drug Levodopa stands in for the damaged neurons that ought to produce dopamine. Currently there are also other drugs that are used as dopamine to stimulate the nerve endings. Patients may also go through some therapies and put on special diets all aimed at improving the dopamine levels. In case the disease has advanced a patient may have to be treated through surgeries which may include deep brain stimulation with implanted electrodes. however, the treatments that have been mentioned above only work to mitigate on the effects of the symptoms of Parkinson’s disease but do not slow down or reverse the damage that the disease cause on the nerve cells in the brain. It has also been reported that even with the above treatments it reaches a time when the patient’s condition will deteriorate. There has also been a problem with early detection of the disease as mostly the disease is diagnosed lately after a patient has lost most of his dopamine and the nerve cells in the brain are already damaged. It is with the view of seeking a whole treatment for the disease that scientists began research on the ability of the stem cells to treat Parkinson’s disease.

The stem cell therapy may help

Parkinson’s disease is a dark medical field, its immediate cause isn’t known but scientists have today known which part of the brain is affected by this disease as well as the cells that are often affected by the disease. the stem cells which are known replicate several times giving rise to new cells are already being used to grow dopamine producing nerve cells in laboratories to aid the study of this disease. The stem cells are majorly used in the labs when the genetic cause of the disease is known. The disease destroys cells but through stem cells therapy, the damaged cells can be replaced by healthy new cells of the same type.

Research studies of 1980-90s bred hope

Parkinson's DiseaseIn 1980-90s researchers worked to find out if the cell replacement therapy could be used to quell the harmful effects of the Parkinson’s disease. The findings of these researchers have since been a foundation upon which current researchers increase the scope of their study on the effects of cell replacement therapy on the Parkinson’s disease. Particularly, Swedish, American and Canadian researchers have transplanted the developing nigral dopamine-producing neurons from human fetuses into animals and human patients with Parkinson’s disease. In these studies there were some great improvements while in other cases there were only modest changes.

A new study has since resurfaced. This study is much larger in scope and will include clinical trials. The study titled TRANSEURO aims at addressing the issues of consistency in efficacy as well as reduction in side effects associated with stem cell transplant. There is optimism that stem cell transplant to replace the damaged nerve cells could help in fighting this disease. Dr. Dalal Akoury (MD) is an expert in integrative medicine and a founder of AWAREmed Health and Wellness Center located at Myrtle Beach South Caroline. Visit her for more information on most lifestyle diseases.

Stem Cell Therapy May Offer an Effective Parkinson’s Disease Treatment

 

Facebooktwitterpinterestlinkedin